Literature DB >> 1748636

Skeletal myoblasts utilize a novel beta 1-series integrin and not alpha 6 beta 1 for binding to the E8 and T8 fragments of laminin.

H von der Mark1, J Dürr, A Sonnenberg, K von der Mark, R Deutzmann, S L Goodman.   

Abstract

The E8 fragment of laminin stimulates myoblast attachment and locomotion. Myoblast attachment to laminin/E8 was blocked by anti-integrin antibodies against beta 1-chains but not by antibodies against alpha 6-chains. By contrast, other cell lines (e.g. B16, HT1080, P19, F9, Pys2, 3T3, and 3T6) were blocked both by anti-beta 1 and anti-alpha 6. All cells tested also bound to approximately 125-kDa C-terminal fragments of E8 (T8 and T8'). Immunoprecipitation of surface-iodinated myoblasts revealed beta 1-, alpha 3-, and alpha 5-integrin chains and a novel chain that co-precipitated with anti-beta 1 antibodies running at approximately 95 kDa (reduced). I125-alpha 6 beta 1 was immunoprecipitated from cells whose attachment to E8 was blocked by anti-alpha 6 antibodies. By contrast, little alpha 6 beta 1 could be immunoprecipitated from myoblasts. beta 1-Integrin and the novel alpha-chain (alpha'), Mr approximately 120,000/approximately 95.000 (nonreduced/reduced), from myoblast lysates were retained during affinity chromatography on Engelbreth-Holm-Swarm-laminin affinity columns. beta 1, alpha 1, and the novel alpha' were retained from Rugli cell lysates on Engelbreth-Holm-Swarm-laminin columns. alpha 3 was not bound. When E8 was used as affinity matrix, only beta 1 and alpha' were retained. The N-terminal sequence of Rugli alpha' was homologous to alpha-chains of beta 1-series integrins and was most similar to alpha 6 (9 identical residues out of 14). However, there were distinctive differences; in particular, 2 residues were deleted in comparison with alpha 6.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1748636

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

1.  Impaired axonal regeneration in alpha7 integrin-deficient mice.

Authors:  A Werner; M Willem; L L Jones; G W Kreutzberg; U Mayer; G Raivich
Journal:  J Neurosci       Date:  2000-03-01       Impact factor: 6.167

2.  Expression of alpha7beta1 integrin splicing variants during skeletal muscle regeneration.

Authors:  Minna Kääriäinen; Liisa Nissinen; Stephen Kaufman; Arnoud Sonnenberg; Markku Järvinen; Jyrki Heino; Hannu Kalimo
Journal:  Am J Pathol       Date:  2002-09       Impact factor: 4.307

3.  β1D chain increases α7β1 integrin and laminin and protects against sarcolemmal damage in mdx mice.

Authors:  Jianming Liu; Derek J Milner; Marni D Boppart; Robert S Ross; Stephen J Kaufman
Journal:  Hum Mol Genet       Date:  2011-12-16       Impact factor: 6.150

Review 4.  The role of laminins in basement membrane function.

Authors:  M Aumailley; N Smyth
Journal:  J Anat       Date:  1998-07       Impact factor: 2.610

Review 5.  Laminin isoforms in endothelial and perivascular basement membranes.

Authors:  Lema F Yousif; Jacopo Di Russo; Lydia Sorokin
Journal:  Cell Adh Migr       Date:  2012-12-21       Impact factor: 3.405

Review 6.  Structure and function of the skeletal muscle extracellular matrix.

Authors:  Allison R Gillies; Richard L Lieber
Journal:  Muscle Nerve       Date:  2011-09       Impact factor: 3.217

7.  Outer membrane protein YadA of enteropathogenic yersiniae mediates specific binding to cellular but not plasma fibronectin.

Authors:  H Schulze-Koops; H Burkhardt; J Heesemann; T Kirsch; B Swoboda; C Bull; S Goodman; F Emmrich
Journal:  Infect Immun       Date:  1993-06       Impact factor: 3.441

8.  Localization of integrin subunits alpha 6 and beta 1 during somitogenesis in the long-tailed macaque (M. fascicularis).

Authors:  C S Pow; A G Hendrickx
Journal:  Cell Tissue Res       Date:  1995-07       Impact factor: 5.249

Review 9.  The potential of sarcospan in adhesion complex replacement therapeutics for the treatment of muscular dystrophy.

Authors:  Jamie L Marshall; Yukwah Kwok; Brian J McMorran; Linda G Baum; Rachelle H Crosbie-Watson
Journal:  FEBS J       Date:  2013-05-13       Impact factor: 5.542

Review 10.  Laminin-binding integrins and their tetraspanin partners as potential antimetastatic targets.

Authors:  Christopher S Stipp
Journal:  Expert Rev Mol Med       Date:  2010-01-18       Impact factor: 5.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.